Thomas White International’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$618K Hold
4,586
0.13% 156
2023
Q1
$731K Buy
4,586
+46
+1% +$7.03K 0.15% 139
2022
Q4
$734K Hold
4,540
0.16% 145
2022
Q3
$609K Hold
4,540
0.14% 153
2022
Q2
$695K Hold
4,540
0.14% 148
2022
Q1
$736K Hold
4,540
0.12% 154
2021
Q4
$615K Hold
4,540
0.1% 181
2021
Q3
$490K Hold
4,540
0.07% 199
2021
Q2
$511K Hold
4,540
0.07% 195
2021
Q1
$491K Hold
4,540
0.07% 197
2020
Q4
$486K Hold
4,540
0.08% 187
2020
Q3
$398K Hold
4,540
0.07% 201
2020
Q2
$446K Hold
4,540
0.09% 181
2020
Q1
$346K Buy
+4,540
New +$387K 0.08% 191
2013
Q4
Sell
-150
Closed -$7K 366
2013
Q3
$7K Hold
150
﹤0.01% 346
2013
Q2
$6K Buy
+150
New +$6.56K ﹤0.01% 318

Other funds holding ABBV

Thomas White International's ABBV Position: Q2 2023 in Review

Thomas White International held its AbbVie (ABBV) position steady in Q2 2023 at 4,586 shares worth $618K. The position accounts for 0.13% of the portfolio, ranked #156.

Thomas White International first reported a position in ABBV in Q2 2013 and has held it in 16 quarters since. The position peaked at $736K in Q1 2022. 3,076 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Thomas White International held 4,586 shares of AbbVie worth $618K as of Q2 2023.
  • Thomas White International left its AbbVie share count unchanged in Q2 2023.
  • AbbVie made up 0.13% of Thomas White International's portfolio in Q2 2023, its #156 holding.
  • Thomas White International first reported a position in AbbVie in Q2 2013 and has held it in 16 quarters since.
  • Thomas White International's AbbVie position peaked at $736K in Q1 2022.
  • 3,076 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Thomas White International's 13F filing for Q2 2023, filed 14 Aug 2023.